世界中医药2024,Vol.19Issue(13) :2018-2022,2029.DOI:10.3969/j.issn.1673-7202.2024.13.024

黄芪汤治疗肝硬化及其相关并发症研究进展

Huangqi Decoction in the Treatment of Cirrhosis and Its Related Complications:A Review

徐文施 蒋式骊 张华
世界中医药2024,Vol.19Issue(13) :2018-2022,2029.DOI:10.3969/j.issn.1673-7202.2024.13.024

黄芪汤治疗肝硬化及其相关并发症研究进展

Huangqi Decoction in the Treatment of Cirrhosis and Its Related Complications:A Review

徐文施 1蒋式骊 1张华1
扫码查看

作者信息

  • 1. 上海中医药大学附属曙光医院,上海中医药大学肝病研究所,肝肾疾病病证教育部重点实验室,上海市中医临床重点实验室,上海,201203
  • 折叠

摘要

黄芪汤(黄芪、甘草)始载于《太平惠民和剂局方》,具有补中、益气、生津之效,治疗诸虚不足.黄芪汤为中医经典名方,临床广泛应用于多种辨证属虚损不足的疾病与证候.前期临床观察和实验研究证实,黄芪汤可显著提高肝脏的合成能力,有效延缓肝纤维化和肝硬化进展,并改善肝硬化门脉高压等相关并发症.故就黄芪汤全方、组分及其有效成分在抗肝纤维化,防治肝硬化及其并发症的基础和临床研究进展作一综述.

Abstract

Huangqi Decoction(Astragali Radix and Glycyrrhizae Radix et Rhizoma),first recorded in the Formulary of the Bureau of Taiping People's Welfare Pharmacy(Tai Ping Hui Min He Ji Ju Fang),is known for its functions of tonifying the middle,benefi-ting qi,and generating fluids,and is used to treat various forms of deficiency.As a classic formula in traditional Chinese medicine(TCM),Huangqi Decoction is widely applied in clinical practice for treating a range of diseases and syndromes characterized by deficiency based on syndrome differentiation.Previous clinical observations and experimental studies have confirmed that Huangqi Decoction can significantly enhance the synthetic capacity of the liver,effectively delay the progression of liver fibrosis and cirrho-sis,and improve complications related to portal hypertension caused by liver cirrhosis.This review aimed to summarize the progress in basic and clinical research on Huangqi Decoction,including its whole formula,individual components,and active ingredients,in relation to its anti-fibrotic effects and its role in the prevention and treatment of liver cirrhosis and its complications.

关键词

黄芪汤/皂苷成分/黄酮成分/肝纤维化/肝硬化/门脉高压/研究进展/综述

Key words

Huangqi Decoction/Saponin components/Flavonoid components/Liver fibrosis/Cirrhosis/Portal hypertension/Re-search Progress/Review

引用本文复制引用

基金项目

国家"十二五"重大新药创制创新药物研究开发技术平台建设项目(2012ZX09303009-001)

国家自然科学基金项目(81603532)

上海市科委"科技创新行动计划"临床医学领域科技支撑项目(19401972600)

出版年

2024
世界中医药
世界中医药学会联合会

世界中医药

CSTPCDCHSSCD北大核心
影响因子:1.266
ISSN:1673-7202
参考文献量51
段落导航相关论文